Holiferm

Holiferm transforms conventional batch fermentation into efficient continuous processes and our patented integrated gravity separation technology enables cost competitive large scale production of biosurfactant products. Our products have been quickly adopted by various distributors and environmentally conscious product manufacturers. Holiferm founded to bring environmentally friendly bioproducts to market. Holiferm receives a combined investment of $9.5M from Rhapsody Venture Partners and Clean Growth Fund, known for their contributions in supporting sustainable technology development. Holiferm accelerates the transition to a biosurfactant based economy by using renewable materials to manufacture non-toxic ingredients for industrial and consumer products. Our kiloton scale commercial plant for production of sophorolipid biosurfactants is the first and largest of its kind – and we’re not going to stop there. Investment from Icos Capital’s ICF III fund enables Holiferm to scale-up its activities with the construction of a new R&D lab and pilot plant. Portfolio expanded at the R&D laboratory, starting the development of manufacturing processes for a new range of biosurfactants.